US 8633205
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
granted A61PA61P1/04A61P11/00
Quick answer
US patent 8633205 (Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P11/06, A61P13/08